Search News Year All202620252024202320222021 01/08/2026 Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference Read More 12/29/2025 Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC) Read More 12/12/2025 Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Read More 12/02/2025 Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD Read More 11/20/2025 Zevra Therapeutics, Inc. Announces CFO Transition Read More 11/05/2025 Zevra Reports Third Quarter 2025 Financial Results and Corporate Update Read More 10/29/2025 Zevra Therapeutics to Participate in the Guggenheim Healthcare Innovation Conference Read More 10/27/2025 Zevra Therapeutics Announces Details for Q3 2025 Financial Results Call Read More 10/06/2025 Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Read More 09/18/2025 Zevra Therapeutics Announces Upcoming Oral Presentation at the International Niemann-Pick Disease Alliance (INPDA) Meeting and Poster Presentations at the Child Neurology Society (CNS) Conference on MIPLYFFA® (arimoclomol) and OLPRUVA® (sodium phenylbutyrate) Read More
01/08/2026 Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference Read More
12/29/2025 Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC) Read More
12/12/2025 Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Read More
12/02/2025 Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD Read More
10/29/2025 Zevra Therapeutics to Participate in the Guggenheim Healthcare Innovation Conference Read More
10/06/2025 Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Read More
09/18/2025 Zevra Therapeutics Announces Upcoming Oral Presentation at the International Niemann-Pick Disease Alliance (INPDA) Meeting and Poster Presentations at the Child Neurology Society (CNS) Conference on MIPLYFFA® (arimoclomol) and OLPRUVA® (sodium phenylbutyrate) Read More
News
Careers
Contacts